INS and cancer: Metformin is under intense investigation as an anti-cancer therapy for both tumor cell-autonomous activity as well as indirect activities in lowering systemic glucose and insulin that have largely been attributed to the reduced incidence of certain cancers in diabetic patients taking metformin [29–32].